The value-based healthcare movement's effort to cut costs and improve healthcare outcomes doesn't realize that patients' conditions are rarely homogenous.
There is a way to cultivate, not demonize, collaboration between physicians and pharma.
Question the intuitive "best" practice; never assume we know enough.
The human connection is threatened by a reductive focus on data collection, algorithms, and information transaction.
Physicians won't become obsolete any time soon, but the comprehensive integration of everything we know about well-being could revolutionize medical care.
America must recommit to U.S. medical culture's first principles.
The Supreme Court's recent decision on health care exposes an age-old debate: focus resources on the treatments we have, or set our sights on pricey research for future cures?
Will Silicon Valley lead health care's next revolution -- or miss it?
Soon, you won't only be responsible for managing your disease -- you may also be expected to help find your own cure.
Successfully translating scientific discoveries requires a primal sense of urgency, which some disease foundations seem to have, and many big pharmas appear to need.
We've figured out DNA, but we need to start watching how it interacts with the environment.
The entrepreneur and process methods -- two ways of dealing with the problems created by a business segregated into extreme phenotypes
In the development of drugs, it's too difficult to change things on the fly, and to rapidly pivot in response to an appreciation of customer need
At large, established companies, doing old things more efficiently becomes more important than doing new things. That's the problem.
The challenge for medicine is not only to utilize patient-focused technologies, but also to recognize the unquantifiable benefit that comes from a reassuring nod, a hand on the shoulder
The kind of design thinking championed by Steve Jobs -- human-centered, iterative, and practical -- can fix more than just our gadgets